News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Study Shows Aspirin Can Help Prevent Dangerous Blood Clots


Website www.hrc.govt.nz

7 November 2012

Study Shows Aspirin Can Help Prevent Dangerous Blood Clots

Media Release

An international study, part-funded by the Health Research Council of New Zealand (HRC), shows low-dose aspirin is a cheap and effective way to prevent potentially deadly blood clots in the veins of the leg or in the lungs.

The study, which has just been published in The New England Journal of Medicine, found people with blood clots in the veins of the leg (deep vein thrombosis or DVT) or the lungs (pulmonary embolism or PE), also known as venous thromboembolism (VTE) are less likely to suffer a recurrence of the serious blood clots or a cardiac event if they take low-dose aspirin.

Running since 2003, the ASPIRE study completed recruitment of 822 participants from five countries including Australia, New Zealand, Singapore, India and Argentina. More than a quarter of the patients were recruited in New Zealand, with funding for the New Zealand investigators provided by a $537,000 grant from the Health Research Council of New Zealand.

All the participants previously had DVT or PE that occurred for no particular reason, and had completed on average six months of anticoagulant treatment (generally with warfarin). Participants were randomly allocated to receive either low dose enteric coated aspirin 100mg daily or a matching placebo. On average, participants were followed for three years.

Blood clots in the veins of the leg or the lungs are a common condition and affect about 1 in every 1000 persons in New Zealand and Australia each year.

Dr Tim Brighton, a haematologist in Sydney and principal investigator of the study, said many patients discontinue warfarin therapy after 6 or 12 months of treatment due to the inconvenience of regular blood tests and the increased risks of serious bleeding. However, if warfarin therapy is stopped these patients are at high risk of recurring thrombosis.

“The ASPIRE study found that aspirin reduces the risk of important blood clotting events, including recurrent VTE, myocardial infarction, stroke, or cardiovascular death. We now

have clear evidence that aspirin is of benefit for patients who are unable or do not wish to continue warfarin in the long term.”

Director of the Thrombosis Unit at Auckland Hospital, Dr Paul Ockelford, who led the New Zealand trials, says: “The results of this study will change our practice managing patients with venous thromboembolism, so it’s an exciting development. Unless a patient is a candidate for extended anticoagulants, we now have the evidence to recommend long-term aspirin as it’s not only effective, but also safe and cheap.”

Collaboration

o The study was conducted by NHMRC Clinical Trials Centre at the University of Sydney and investigators in Australia, New Zealand, India, Singapore and Argentina.

o The study was supported by project grants from Australia’s National Health and Medical Research Council, the Health Research Council of New Zealand, the Australasian Society of Thrombosis and Haemostasis, and Bayer HealthCare, Germany. Aspirin and matching placebo were provided without charge by Bayer HealthCare Pharmaceuticals who played no other role in the study.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Eddie Izzard: UK Comedy Legend Returns

Hailed as one of the foremost stand up comedians of his generation. Star of stage and screen. Tireless supporter of charity. Runner. Political campaigner. Fashion Icon... February 2015, Eddie Izzard will bring his massive FORCE MAJEURE world tour to New Zealand with tickets going on sale at 10am on Tuesday 28th October. More>>

Festival Starts 28 Oct: Improv Fest Makes Up New Show

For any other festival, finding out less than two weeks from showtime that half the cast of a programmed show can’t make it to New Zealand would be a nightmare. Instead, the New Zealand Improv Festival Director Jennifer O’Sullivan saw an opportunity ... More>>

NZ Music Awards Finalists: Lorde, Sol3 Mio Top 2014 Tuis Charge

Lorde has taken the music world by storm during the past year and she co-leads the 2014 Tui charge with five finalist spots. Joining her is newcomer family opera trio, Sol3 Mio. They are followed closely by Ladi6 and David Dallas, both up for four awards each. More>>

From 'Luther' Creator: Major New Zealand Crime Series For BBC

Libertine Pictures and writer Neil Cross have teamed up with leading international TV producer Carnival Films to develop a major new crime series set in Rotorua. Libertine will develop the contemporary drama series with Carnival, producer of internationally-acclaimed British period drama Downton Abbey, for the BBC. More>>

ALSO:

Family Statement: Death Of Ewen Gilmour

“Ewen was a much loved and cherished member of our family, he was a larger than life character and by his very nature was kind, generous and always giving of his time to those who asked for his help." More>>

ALSO:

Auckland: St. Jerome's Laneway Festival - Line-Up Announced

Traversing seven cities and three countries, the festival has well and truly settled into its home in each state. From the grassy knolls and towering silos at home in Auckland, to the sparkling backdrop of the Maribyrnong... More>>

Scoop Review Of Books: No Longer An Island

Simon Nathan reviews 'Zealandia: Our Continent Revealed': The idea that New Zealand is part of a large submerged continent is not new... There was renewed interest in the extent of offshore New Zealand from the 1970s onwards with the start of offshore drilling for oil and gas, and this was given impetus by a UN agreement which allowed countries to claim an Extended Continental Shelf (ECS). More>>

Art: Simon Denny Recreates Kim Dotcom’s Personal Effects

Who owns what? How has the internet changed our relation to the world? These are two of the many questions Simon Denny raises in the latest exhibition at the Adam Art Gallery, opening on Saturday 4 October. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news